ZYBT Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED
Zhengye Biotechnology Holding Ltd

Zhengye Biotechnology Holding Ltd. Stock Analysis ZYBT

United States Health Care Small Cap
Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. The company is headquartered in Jilin, Jilin and currently employs 275 full-time employees. The company went IPO on 2025-01-07. The firm markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The firm owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The firm also engages in vaccines for treating livestock. The firm mainly conducts its business in the domestic market. The firm mainly conducts its business in the domestic and overseas market.
Read More

ZYBT Chart

United States Health Care Small Cap

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$7.30$9.97

Today's Open

$8.43

Volume

847.98K

P/E Ratio (TTM)

9,728.44

52 Week Range

$3.50$10.47

Market Cap

485.76M

Avg. Volume

709.82K

Dividend Yield

-

Financial Metrics & Statements

  • Per Share Data
  • Ratios
  • Statements
No data

No Data Available!

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.